Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus
- PMID: 385188
- PMCID: PMC1537673
Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus
Abstract
To investigate the suggestion that qualitative immunochemical characteristics of antibodies to DNA (anti-DNA) may be of importance in the pathogenesis of nephritis in systemic lupus erythematosus (SLE), we used the Crithidia luciliae (CL) immunofluorescence test to determine the titre, immunoglobulin (Ig) class and complement-fixing activity of anti-DNA in thirty-five patients with active SLE. Eighteen of these patients had active lupus nephritis (Group I) and the remaining seventeen had no clinical evidence of renal involvement (Group II). Anti-DNA was detected in twenty-eight patients, and was present more frequently and in higher titre (P less than 0.01) in Group I than in Group II. Anti-DNA of all three Ig classes studied (IgG, IgM and IgA) was present in twenty-three out of twenty-eight cases. The ratio of IgG to IgM anti-DNA did not differ in the two groups of patients. Complement-fixing antibodies were detected in thirteen patients in Group I and five patients in Group II. The titre of complement-fixing activity was strongly correlated with titre of anti-DNA. DNA-binding capacity was also determined in these by a millipore filter (MF) assay. A highly significant correlation between DNA binding by MF and CL was found in Group I patients, while no correlation was found in Group II patients. These findings suggest that (1) anti-DNA with specificity for determinants found in CL, presumably native DNA, are more highly correlated with the presence of active renal lupus than are antibodies directed toward other DNA determinants, and (2) the major characteristic of anti-DNA found to be associated with nephritis was quantity of antibody. Most patients had anti-DNA of all Ig classes regardless of the presence of renal disease. Complement-fixing activity of anti-DNA could not be related to the occurrence of renal disease independently of anti-DNA titre.
Similar articles
-
Complement-fixing antibodies to dsDNA detected by the immunofluorescence technique on Crithidia luciliae. A critical appraisal.J Rheumatol. 1985 Dec;12(6):1109-17. J Rheumatol. 1985. PMID: 3912506
-
Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method.J Rheumatol. 1979 Jul-Aug;6(4):389-96. J Rheumatol. 1979. PMID: 392093
-
[Anti-DNA determination using Crithidia luciliae. Specificity and clinical usefulness in systemic lupus erythematosus].Rev Rhum Mal Osteoartic. 1982 Apr;49(5):345-50. Rev Rhum Mal Osteoartic. 1982. PMID: 7048503 French.
-
Laboratory procedures used in the diagnosis of systemic lupus erythematosus: a review.Am J Med Technol. 1977 Sep;43(9):856-63. Am J Med Technol. 1977. PMID: 73351 Review.
-
[Antibodies against native DNA. The methods for their demonstration. Their diagnostic and pathogenetic importance in systemic lupus erythematosus].Vutr Boles. 1976;15(2):18-26. Vutr Boles. 1976. PMID: 59467 Review. Bulgarian. No abstract available.
Cited by
-
Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).Clin Rheumatol. 1987 Jun;6 Suppl 1:56-73. doi: 10.1007/BF02200721. Clin Rheumatol. 1987. PMID: 3304800 Review.
-
Measurement of anti-DNA antibodies: a reappraisal using five different methods.Ann Rheum Dis. 1987 Jun;46(6):448-56. doi: 10.1136/ard.46.6.448. Ann Rheum Dis. 1987. PMID: 3498446 Free PMC article.
-
A comparison of assays used for the detection of antibodies to DNA.Clin Rheumatol. 1990 Mar;9(1 Suppl 1):63-72. doi: 10.1007/BF02205553. Clin Rheumatol. 1990. PMID: 2203595 Review.
-
Anti-DNA antibodies of IgA class in patients with systemic lupus erythematosus.Rheumatol Int. 1986;6(2):53-5. doi: 10.1007/BF00541504. Rheumatol Int. 1986. PMID: 3764305
-
Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays.Rheumatol Int. 1981;1(1):29-34. doi: 10.1007/BF00541220. Rheumatol Int. 1981. PMID: 6981180
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous